Investment aims to enhance brain monitoring solutions and expand operational capabilities.
Innovating EEG Monitoring
Zeto, a leader in AI-powered EEG brain monitoring, has raised $31 million in a funding round led by MindWorks Global (MWG). The funds will support:
- Expansion of commercial and operational teams.
- R&D enhancements to advance product offerings.
- Growth initiatives to increase adoption across healthcare institutions.
The Zeto ONE System
Zeto’s FDA-cleared ONE system revolutionizes EEG monitoring with:
- A user-friendly headset featuring 21 soft-tip electrodes in the standard 10-20 EEG configuration.
- AI-driven notifications for real-time seizure activity detection.
- Cloud integration enabling remote data access, interpretation, and workflow management by board-certified neurologists.
- Minimal training required for healthcare professionals, making it suitable for emergency and routine applications.
Market Impact
The system’s seamless integration with Zeto Cloud supports comprehensive EEG workflows, including:
- Live monitoring with video and audio recording.
- Patient scheduling and report generation tools.
- Broad applications in critical care and diagnostic settings, enhancing efficiency and outcomes.
Leadership and Vision
Founder and CEO Aswin Gunasekar emphasized the company’s commitment to innovation:
“Zeto has reached a pivotal milestone, earning a reputation for game-changing innovation and experiencing rapid adoption by leading healthcare institutions. With MindWorks Global as partners, we are poised to drive meaningful societal impact and significant revenue.”
With a strong focus on scaling its EEG platform, Zeto aims to address critical needs in brain monitoring through cutting-edge AI technologies and streamlined workflows.
Follow MEDWIRE.AI and stay informed on advancements in neurotechnology and AI-driven healthcare solutions.
